AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Monetizing a small business can significantly increase profits. Explore various strategies to enhance your income potential.
19,626 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
BitGo's latest move adds to the crypto job-cut trend as it slashes about 15% of its workforce to refocus on stablecoi...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...
A wave of quantum funding is moving beyond labs to big-name backers. BlackRock, Nvidia, and Temasek are leading a sur...
As AI spending surges, a handful of ETFs offer broad, diversified access to the AI boom. Four funds map to the AI sta...
A year after Rocket Companies’ $1.75 billion acquisition of Redfin, the integration is accelerating. Joe Rath, now he...
iQIYI’s stock trades near $1 after a disappointing Q1 report, but the company’s AI pivot and new capital moves set up...
The Nasdaq surged in the first half of 2026 as AI infrastructure names led a broad rally. Three AI stocks are showing...
Gold’s surge in early 2026 has sparked crowded-trade warnings. This article ranks three retiree-friendly stock picks ...
A private Korean shipowner is quietly reshaping oil flows through the Strait of Hormuz, turning covert shuttle runs i...
Casetlake LP has offered 6.90 per share in cash for EasyJet, valuing the airline around £5.2B, but investors remain d...
Investors chase value, momentum and income as markets wobble in July 2026. This report breaks down the retirement por...